Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Beam Therapeutics (BEAM) Preferred Shares Issued (2019)

Beam Therapeutics (BEAM) has disclosed Preferred Shares Issued for 1 consecutive years, with $37.9 million as the latest value for Q1 2019.

  • Quarterly Preferred Shares Issued changed N/A to $37.9 million in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $37.9 million through Dec 2019, changed N/A year-over-year, with the annual reading at $37.9 million for FY2019, N/A changed from the prior year.
  • Preferred Shares Issued for Q1 2019 was $37.9 million at Beam Therapeutics.
  • The five-year high for Preferred Shares Issued was $37.9 million in Q1 2019, with the low at $37.9 million in Q1 2019.